Envista Holdings Corporation (NVST) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jul 03 2026 to Jun 27 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Envista Holdings Corporation  (NYSE: NVST)


Envista Holdings's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Envista Holdings's ROI in the second quarter of 2026?
Envista Holdings Corporation achieved a return on average invested assets (ROI) of 2.06 % in its second quarter of 2026, this is above NVST's average return on investment of -1.13%.
Envista Holdings Corporations investments during the 12 months ending in the second quarter of 2026 are valued at $4 billion

ROI has improved compared to 1.49% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 156 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1309 to 2240.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 26 2025)
III. Quarter		 (Jun 27 2025)
II. Quarter
Y / Y Investment Change TTM 5.29 % 5.43 % -2.42 % -11.09 % -17.27 %
Y / Y Net Income Change TTM 76.58 % - - - -
Investment (TTM) in Millions 4,790 4,519 4,591 4,534 4,584
Return On Investment (TTM) 2.06 % 1.49 % 1.04 % 0.35 % 1.23 %
NVST's Overall Ranking # 2240 # 1309 # 1676 # 2115 # 1635
Seq. Investment Change TTM 1.13 % 1.03 % 2.14 % 0.89 % 1.27 %
Seq. Net Income Change TTM 40.32 % 44.04 % 207.19 % -71.56 % -
Net Income (TTM) in Millions 95 68 47 15 54

NVST Company Profile >> Back to NVST Roi Comparisons >> See Annual NVST Return On Investment



Return On Investment NVST's Ranking
Within: No.
Industry # 52
Sector # 157
Overall # 2240

Return On Investment Statistics
High Average Low
6.92 %
-1.13 %
-26.95 %
(Oct 01 2021)   (Sep 27 2024)







Financial Statements
Envista Holdings's II. Quarter Investments $ 4,790 Millions NVST's Balance sheet
Envista Holdings's II. Quarter Income $ 54 Millions Quarterly NVST's Income Statement
NVST's Income by Division See NVST's Income by Division


NVST Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 4,555 4,213 5,572 5,078 5,366
Y / Y Investment Growth 8.11 % -24.39 % 9.74 % -5.38 % 3.36 %
Net Income in Millions 47 -1,119 -100 243 341
Y / Y Net Income Growth - - - -28.6 % 922.52 %
Annual Return On Investment 1.03 % -26.55 % -1.8 % 4.79 % 6.35 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 1.03 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NVST's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NVST's Competitors
Subscribers only: Roi for Envista Holdings's Suppliers
Subscribers only: Return On Investment for NVST's Customers

Other Ratios
NVST's Roa NVST's Inventory Turnover Ratio NVST's Growth Rates NVST's Dividend Statistics
NVST's Profitability Ratios NVST's Asset Turnover Ratio NVST's Dividend Growth
NVST's Roe NVST's Valuation Ratios NVST's Financial Strength Ratios NVST's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 03 2026, within Healthcare Sector ROI
Vericel Corporation  5.58 %
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %
Pfizer Inc  2.53 %
Mimedx Group Inc   2.38 %
Bio rad Laboratories Inc   2.34 %
Lifemd Inc   2.32 %
Alkermes Plc   2.31 %
Becton Dickinson And Company  2.22 %
Revvity Inc  2.18 %
Envista Holdings Corporation  2.06 %
Immucell Corporation  1.95 %

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.